Antares Pharma Inc (ATRS)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

100 PRINCETON SOUTH EWING, NJ 08628

Antares Pharma is a pharmaceutical company focused on self-injection pharmaceutical products and topical gel-based products. Co.'s subcutaneous and intramuscular injection products include Vibex disposable pressure-assisted auto injectors, Vision reusable needle-free injectors, and disposable pen injectors. In the injector area, Co. has licensed its reusable needle-free injection device for use with human growth hormone to Teva Pharmaceutical Industries, Ltd., Ferring Pharmaceuticals BV and JCR Pharmaceuticals Co., Ltd. In the gel-based area, Co.'s products include Anturol, an oxybutynin transdermal delivery gel for the treatment of overactive bladder.

Data as of 2020-09-12
Market Cap460.08 Million Shares Outstanding166.094 Million Avg 30-day Volume1.002 Million
P/E Ratio69.0 Dividend Yield EPS0.04
Price/Sales3.343 Price cash flow ratio46.2 Price free cash flow ratio74.7
Book Value0.35 Price to Tangible Book8.0 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.10027
BETA1.23837 52-week High/Low5.13 / 1.6 Stddev0.1671

Are you looking for this stock instead?

View SEC Filings from ATRS instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 1 100.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 158 154 2.6% 48 (3.13%) 47 (3.01%) 2.13%
13F shares: 71.128 Million 66.67 Million 6.69% 19.353 Million 20.083 Million -3.64%
% Ownership 42.8239 40.269 6.34% 11.6518 12.1303 -3.94%
New Positions: 20 21 -4.76% 7 11 -36.36%
Increased Positions 56 54 3.7% 18 22 -18.18%
Closed Positions 14 26 -46.15% 5 7 -28.57%
Reduced Positions 45 48 -6.25% 18 12 50.0%
Total Calls 76.275 Thousand 80.218 Thousand -4.92% 21.6 Thousand 500 4220.0%
Total Puts 128.867 Thousand 237.192 Thousand -45.67% 38.6 Thousand 52.7 Thousand -26.76%
PUT/CALL Ratio 1.69 2.96 -42.91% 1.79 105.4 -98.3%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ATRS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ATRS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

JACOB LEONARD S

  • Director
253,042 2020-06-11 3

APPLE ROBERT F PRESIDENT & CEO

  • Officer
  • Director
2,295,155 2020-06-11 5

GARRITY THOMAS J

  • Director
224,406 2020-06-11 3

GUETH ANTON

  • Director
429,456 2020-06-11 2

ROCHE ROBERT P JR

  • Director
142,365 2020-06-11 1

GRAHAM PETER J EVP GENERAL COUNSEL, SECRETARY

  • Officer
502,125 2020-06-11 3

POWELL FRED M EXECUTIVE VICE PRESIDENT & CFO

  • Officer
630,065 2020-06-11 3

GREENLEAF PETER

  • Director
54,193 2020-06-11 1

SMITH KAREN L.

  • Director
54,193 2020-06-11 1

SAMSON MARVIN

  • Director
51,751 2020-01-10 4

TURSI JAMES PATRICK EVP, CHIEF MEDICAL OFFICER

  • Officer
45,205 2019-06-13 0

GONELLA JACQUES

  • Director
9,385,848 2019-02-26 0

MUCKENHIRN KEITH E VP/CONTROLLER & INTERIM CFO

  • Officer
50,000 2016-09-04 0

FICKENSCHER JAMES E SENIOR VICE PRESIDENT & CFO

  • Officer
391,266 2016-06-02 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD PARTNERS, LP

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2015-09-28 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD PARTNERS, LP

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
73,187,835 2015-07-17 0

HOBBS EAMONN P PRESIDENT & CEO

  • Officer
  • Director
435,990 2015-06-22 0

STACEY JENNIFER EVANS SVP, GENERAL COUNSEL & SECTY

  • Officer
92,042 2015-05-28 0

WOTTON PAUL K PRESIDENT AND CEO

  • Officer
  • Director
937,725 2014-05-29 0

DAVE KAUSHIK J EXECUTIVE VICE PRESIDENT

  • Officer
265,028 2013-06-03 0

SHROTRIYA RAJESH C

  • Director
177,628 2012-05-17 0

SADOWSKI PETER L SENIOR VICE PRESIDENT

  • Officer
0 2012-05-17 0

CARRARA DARIO SENIOR VICE PRESIDENT (1)

  • Officer
27,500 2010-12-07 0

STOVER JACK E PRESIDENT AND CEO

  • Officer
  • Director
276,666 2008-05-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments